Government report links Avandia to heart attacks
The diabetes drug Avandia produced by GlaxoSmithKline is linked with tens of thousands of heart attacks, and drugmaker GlaxoSmithKline knew of the risks for years but worked to keep them from the public, according to a Senate committee report released on 20., February of 2010. The senate report by the Senate Finance Committee also criticized the FDA, [...]
Continue reading...18. February 2010
FDA issues warning on Advair, Symbicort, Foradil and Serevent
The Food and Drug Administration has issued warnings on Advair, Symbicort, Foradil and Serevent. The FDA said they should be used only by asthmatics who can’t control their lung disease with other medications — and then only for the shortest time possible. The FDA is taking steps to curb use of some long-acting asthma drugs taken [...]
Continue reading...9. November 2009
Wide Eye Schnapps Class Action Lawsuit
Wide Eye Schnapps FTC Decision & OrderFTC Enters Into Final Consent Agreement Regarding Product Claims The FTC entered a final consent agreement with Constellation Brands concerning the FTC’s charges that ads for Wide Eye caffeinated schnapps were deceptive. Wide Eye was a schnapps product containing 30 percent alcohol by volume. Ad claims included “Wake Up @WideEye.com,” [...]
Continue reading...20. January 2009
Avandia Drug Recall
Avandia produced by GlaxoSmithKline, is an oral diabetes medication intended to help those with type-2 diabetes better control their blood glucose levels. Generically classified as a thiazoliodinedione, Avandia is not indicated for those with insulin-dependent (type-1) diabetes. FDA scientists estimated in July 2007 that Avandia was associated with approximately 83,000 heart attacks since the drug came to [...]
Continue reading...27. July 2008
Merck’s Vioxx $4.85 billion payouts to begin in August
Merck & Company will begin funding cto resolve state and federal claims over its painkiller Vioxx. The first payment of $500 million is scheduled for August 6; additional payments will follow. Merck said it met its threshold to make these payouts and waived its right to walk away from last November’s agreement to settle roughly [...]
Continue reading...27. July 2008
FDA recalls Zyprexa
Zyprexa was FDA approved for the short-term treatment of acute manic episodes in bipolar disorder. The worlds best selling schizophrenia drug, Zyprexa sales account for 40% of Eli Lillys $11.08 billion in sales. There have been many questions regarding the popular drug Zyprexa and its safety. Linked to 288 reported Zyprexa diabetes cases, including 23 [...]
Continue reading...
20. February 2010
0 Comments